e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Lung cancer: treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biologically-targeted therapy of NSCLC-our first experience with ZD 1839
M. Pesck, B. Eliasova (Plzen, Czech Republic)
Source:
Annual Congress 2002 - Lung cancer: treatment
Session:
Lung cancer: treatment
Session type:
Thematic Poster Session
Number:
2935
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pesck, B. Eliasova (Plzen, Czech Republic). Biologically-targeted therapy of NSCLC-our first experience with ZD 1839. Eur Respir J 2002; 20: Suppl. 38, 2935
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Our clinical experience in surgical therapy of patients with bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 344s
Year: 2002
Idiophatic tracheal stenosis, first experience with conservative treatment at high altitude, La Paz- Bolivia.Omar Hidalgo MD.interventional pulmonologist.Rodrigo PachecoMD.Thoracic surgeon Rita Villalobos MD.Anatomic patholigist.
Source: International Congress 2018 – Use of stents for tracheal stenosis
Year: 2018
First-line therapy
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Mina Gaga lecture
Source: Virtual Congress 2020 – Early career member: activities, opportunities and motivations
Year: 2020
Mina Gaga lecture
Source: Virtual Congress 2021 – Keys to success in science
Year: 2021
Clinical experience in surgical therapy of 184 patients with bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 626s
Year: 2004
Clinical experience in surgical therapy of 257 patients with bronchiectasis
Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology
Year: 2007
The side-effects of TB therapy: myth and reality
Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties
Year: 2005
Prof. John Guy Widdicombe, 1925–2011: an appreciation of an eminent respiratory physiologist
Source: Eur Respir J 2011; 38: 1243-1244
Year: 2011
Radiation oncology perceptive: radiotherapist considerations for concurrent chemo-RT
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019
The 1954 Nancy meeting; what the challenges were
Source: Annual Congress 2004 - The First European Respiratory Meeting, 50 years on
Year: 2004
Infliximab for treating sarcoidosis, portuguese experience
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
Source: Eur Respir J 2007; 29: 117-126
Year: 2007
Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis
Source: Annual Congress 2007 - Controversies in surgical oncology
Year: 2007
Introductory lecture in memoriam: Professor Philip Quanjer
Source: International Congress 2017 – Mission impossible? Implementing a whole package of new reference values for lung function
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept